ABBVIE INC. (ABBV)
AbbVie Receives Positive CHMP Opinion for Upadacitinib (RINVOQ®) for the Treatment of Adults and Adolescents with Severe Alopecia Areata
AbbVie Receives Positive CHMP Opinion for Upadacitinib (RINVOQ®) for the Treatment of Adults and Adolescents with Severe Alopecia Areata
SES Investors Have Opportunity to Lead SES AI Corporation Securities Fraud Lawsuit with the Schall Law Firm
Amneal Pharmaceuticals, Inc. - Zambon and Amneal Announce Positive CHMP Opinion for Hopledo® (IPX203) for Adults withParkinson’s Disease and Moderate to Severe Motor Fluctuations
AbbVie Receives Positive CHMP Opinion for Upadacitinib (RINVOQ®) for the Treatment of Adults and Adolescents with Non-segmental Vitiligo
Zambon and Amneal Announce Positive CHMP Opinion for Hopledo® (IPX203) for Adults with Parkinson’s Disease and Moderate to Severe Motor Fluctuations
IQM Named a Major Player in the IDC MarketScape: Worldwide Quantum Computing 2026 Vendor Assessment
Identifying Details of New Security-SUMMIT P4
Omdia:2026年全球智慧型手機平均售價將達到565美元,廠商將優先考慮價值而非銷售量
Max It Company announcement: Filing an appeal to the Supreme Court focusing mainly on the VAT liability on fees paid regarding international transactions, continued
Capital market presentation June 2026